Wells Fargo raised the firm’s price target on HCA Healthcare to $365 from $315 and keeps an Equal Weight rating on the shares. The firm notes Hospital results and guides in Q2 generally exceeded expectations. Wells cites higher estimates and rolling forward for the price target raise. The firm expects the second half of 2024 fundamentals to remain fairly strong but 2025/2026 seems likely to be more normalized.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HCA:
- HCA Healthcare price target raised to $392 from $335 at Cantor Fitzgerald
- HCA Healthcare price target raised to $378 from $329 at RBC Capital
- HCA Healthcare price target raised to $390 from $375 at Truist
- HCA Healthcare price target raised to $390 from $345 at Oppenheimer
- HCA Healthcare price target raised to $396 from $367 at Leerink
Questions or Comments about the article? Write to editor@tipranks.com